{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12297018", "DateCompleted": {"Year": "2002", "Month": "12", "Day": "03"}, "DateRevised": {"Year": "2019", "Month": "11", "Day": "06"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1225-8687", "JournalIssue": {"Volume": "35", "Issue": "3", "PubDate": {"Year": "2002", "Month": "May", "Day": "31"}}, "Title": "Journal of biochemistry and molecular biology", "ISOAbbreviation": "J Biochem Mol Biol"}, "ArticleTitle": "Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells.", "Pagination": {"StartPage": "337", "EndPage": "342", "MedlinePgn": "337-42"}, "Abstract": {"AbstractText": ["Many components that are derived from medicinal or dietary plants possess potential chemopreventive properties. Curcumin, a yellow coloring agent from turmeric (Curcuma longa Linn, Zingiberaceae), possesses strong antimutagenic and anticarcinogenic activities. In this study, we have found that curcumin inhibits the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced nuclear factor kB (NF-kappaB) activation by preventing the degradation of the inhibitory protein IkBalpa; and the subsequent translocation of the p65 subunit in cultured human promyelocytic leukemia (HL-60) cells. Alternatively, curcumin repressed the TPA-induced activation of NF-kappaB through direct interruption of the binding of NF-kappaB to its consensus DNA sequences. Likewise, the TPA-induced DNA binding of the activator protein-1 (AP-1) was inhibited by curcumin pretreatment."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 151-742, South Korea."}], "Identifier": [], "LastName": "Han", "ForeName": "Seong-Su", "Initials": "SS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Keum", "ForeName": "Young-Sam", "Initials": "YS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Seo", "ForeName": "Hyo-Joung", "Initials": "HJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Surh", "ForeName": "Young-Joon", "Initials": "YJ"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Korea (South)", "MedlineTA": "J Biochem Mol Biol", "NlmUniqueID": "9702084", "ISSNLinking": "1225-8687"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticarcinogenic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Carcinogens"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "I-kappa B Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "NFKBIA protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factor AP-1"}, {"RegistryNumber": "139874-52-5", "NameOfSubstance": "NF-KappaB Inhibitor alpha"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}, {"RegistryNumber": "NI40JAQ945", "NameOfSubstance": "Tetradecanoylphorbol Acetate"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anticarcinogenic Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Carcinogens"}, {"QualifierName": [], "DescriptorName": "Consensus Sequence"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Curcumin"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": [], "DescriptorName": "Electrophoretic Mobility Shift Assay"}, {"QualifierName": ["physiology"], "DescriptorName": "Genes, Regulator"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "HL-60 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "I-kappa B Proteins"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Leukemia, Myeloid"}, {"QualifierName": [], "DescriptorName": "NF-KappaB Inhibitor alpha"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Promoter Regions, Genetic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Protein Transport"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tetradecanoylphorbol Acetate"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Transcription Factor AP-1"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "9", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2002", "Month": "12", "Day": "4", "Hour": "4", "Minute": "0"}, {"Year": "2002", "Month": "9", "Day": "26", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12297018", "10.5483/bmbrep.2002.35.3.337"]}}], "PubmedBookArticle": []}